Business
Allergy Therapeutics: Granting of Awards
Allergy Therapeutics: Granting of Awards.
About this update from Allergy Therapeutics Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 5901T\n Allergy Therapeutics PLC\n 25 November 2021\n \n \n \n \n \n \n \n \n \n \n Allergy Therapeutics plc\n \n \n (\"Allergy Therapeutics\" or the \"Group\")\n \n \n \n \n \n Vesting and Granting of Awards under Long Term Incentive Plan \n \n \n \n \n \n Allergy Therapeutics (AIM: AGY), the fully integrated pharmaceutical company specialising in allergy vaccines, announces that\n :\n \n \n \n \n \n Vesting of Award\n \n \n Performance conditions attaching to provisional awards (\"Awards\") made pursuant to the Company's Long Term Incentive Plan (\"LTIP\") for the three years ended 1 November 2021, details of which were announced on 1 November 2018, have been met in part.\n \n \n Consequently, on 22 November 2021, Allergy Therapeutics granted certain of its director's options (\"Options\") over the Company's Ordinary Shares of 0.1 pence in replacement for the Awards made under the LTIP as follows:\n \n \n \n \n \n Director\n \n \n \n \n Percentage of Award Vested\n \n \n \n \n Total number of Ordinary Shares over which Options granted \n \n \n \n \n Exercise Price\n \n \n \n \n \n \n M\n anuel Llobet\n \n \n \n \n 89.3%\n \n \n \n \n 803,700\n \n \n \n \n 0.1 pence\n \n \n \n \n \n \n Nick Wykeman\n \n \n \n \n 89.3%\n \n \n \n \n 401,850\n \n \n \n \n 0.1 pence\n \n \n \n \n \n \n \n \n In accordance with the rules of the LTIP, \n 50% of these Options are exercisable immediately and the remaining 50% are subject to a holding period of three years. The exercise period is ten years from date of grant. \n \n \n Granting of Award\n \n \n Pursuant to the Company's Long Term Incentive Plan (\"LTIP\") t\n he following conditional awards of Ordinary Shares of 0.1 pence each were made to Executive Directors at a nominal cost of 0.1 pence each on 22 November 2021 (\"New Awards\").\n \n \n \n \n \n \n \n \n Executive Director\n \n \n \n \n Number of Conditional shares awarded (New Awards)\n \n \n \n \n \n \n Manuel Llobet\n \n \n \n \n 900,000\n \n \n \n \n \n \n Nick Wykeman\n \n \n \n \n 450,000\n \n \n \n \n \n \n \n \n \n \n \n The New Awards have been granted in accordance with the LTIP rules and vesting is conditional on the satisfaction of performance conditions in respect of earnings growth and share price growth over three year...